Meghan R. Flanagan - Concepedia

Author

Meghan R. Flanagan

Also Known As

Flanagan, Meghan R., Florian Fitzal, M R Flanagan, M. Flanagan, Meghan R. Flanagan, Meghan Flanagan, Meghan R Flanagan, Meghan R. Flanagan, Meghan Rose Flanagan

Publications

882

Citations

H-Index

Concepts

All Affiliations

University of Washington Fred Hutch Cancer Center Memorial Sloan Kettering Cancer Center University of Washington Medical Center Cleveland Clinic

About

Meghan R. Flanagan is an author at University of Washington specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	458
2	Public Health	3	3	120
3	Health Sciences	1	1	74
4	Biostatistics	1	1	48
5	Family Medicine	1	1	59

Meghan R. Flanagan

Publications

762

Citations

H-Index

Page 1

	Year	Citations
A Comparison of Patient-Reported Outcomes After Breast-Conserving Surgery and Mastectomy with Implant Breast Reconstruction Meghan R. Flanagan, Emily C. Zabor, Anya Romanoff, Annals of Surgical Oncology Implant Breast ReconstructionPatient-reported OutcomesPostoperative ConsiderationPost-operative CareOutcomes Research	2019	156
NCCN Guidelines® Insights: Breast Cancer Screening and Diagnosis, Version 1.2023 Therese B. Bevers, Bethany L. Niell, Jennifer L. Baker, Journal of the National Comprehensive Cancer Network	2023	121
Pleomorphic Lobular Carcinoma In Situ: Radiologic–Pathologic Features and Clinical Management Meghan R. Flanagan, Mara H. Rendi, Kristine E. Calhoun, Annals of Surgical Oncology Pleomorphic Lobular CarcinomaMedicineHead And Neck CancerNeck OncologyOncology	2015	74
Effects of Gender Bias and Stereotypes in Surgical Training Sara P. Myers, Mohini Dasari, Joshua B. Brown, JAMA Surgery	2020	60
Primary cesarean section and adverse delivery outcomes among women of very advanced maternal age Michael K. Richards, Meghan R. Flanagan, Alyson J. Littman, Journal of Perinatology Family MedicineCesarean HealthPrimary Cesarean SectionMaternal ComplicationGynecology	2016	59
Chemoprevention Uptake for Breast Cancer Risk Reduction Varies by Risk Factor Meghan R. Flanagan, Emily C. Zabor, Michelle Stempel, Annals of Surgical Oncology Breast OncologyCancer RiskMedicineChemoprevention UptakeEpidemiology Of Cancer	2019	48
Accuracy of Preoperative Breast MRI Versus Conventional Imaging in Measuring Pathologic Extent of Invasive Lobular Carcinoma Keegan Hovis, Janie M. Lee, Daniel S. Hippe, Journal of Breast Imaging	2021	41
Adjuvant Endocrine Therapy in Patients with Ductal Carcinoma In Situ: A Population-Based Retrospective Analysis from 2005 to 2012 in the National Cancer Data Base Meghan R. Flanagan, Mara H. Rendi, Vijayakrishna K. Gadi, Annals of Surgical Oncology Endocrine OncologySurgical OncologyBreast OncologyAdjuvant Endocrine TherapyMedicine	2015	29
Status of Intraductal Therapy for Ductal Carcinoma in Situ Meghan R. Flanagan, Susan M. Love, E. Shelley Hwang Current Breast Cancer Reports	2010	28
Axillary Lymphadenopathy After COVID-19 Vaccination in a Woman With Breast Cancer Diana L. Lam, Meghan R. Flanagan JAMA VaccinationImmunologyLymphatic SystemBreast CancerLymphatic Disease	2021	20

Page 1